DrugPatentWatch Database Preview
Details for Patent: 8,263,647
» See Plans and Pricing
Which drugs does patent 8,263,647 protect, and when does it expire?
Patent 8,263,647 protects ADVIL PM and is included in one NDA.
This patent has twelve patent family members in ten countries.
Summary for Patent: 8,263,647
| Title: | Treatment of sleep disturbances |
| Abstract: | The present invention provides a new composition for treating pain-associated sleep disturbances, especially shortened sleep duration, comprising ibuprofen and diphenhydramine. The composition is further prepared as a bilayer tablet or caplet, or alternatively as a soft gelatin capsule composition, to prevent interaction between the active ingredients. |
| Inventor(s): | Cook; Graham D. (Midlothian, VA), Koch; Todd S. (Powhatan, VA), Giamalva; David H. (Gleen Allen, VA), Bianco; Justin (Vineland, VA), Fort; James J. (Midlothian, VA), Doyle; Geraldine (Chatham, NJ), Cooper; Steven (Denville, NJ) |
| Assignee: | Wyeth LLC (Madison, NJ) |
| Application Number: | 12/082,342 |
|
Patent Claim Types: see list of patent claims | Compound; Dosage form; Composition; Use; |
Drugs Protected by US Patent 8,263,647
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | ADVIL PM | diphenhydramine citrate; ibuprofen | TABLET;ORAL | 021394-001 | Dec 21, 2005 | OTC | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,263,647
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 309797 | Start Trial | |||
| Canada | 2434484 | Start Trial | |||
| Germany | 60207383 | Start Trial | |||
| Denmark | 1363608 | Start Trial | |||
| European Patent Office | 1363608 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
